Transfer of bromocriptine across the blood-brain barrier in man-Reference-Cited by-同舟云学术

Transfer of bromocriptine across the blood-brain barrier in man

Published:2009-01-29 Issue:2 Volume:59 Page:88-95
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:

Author:

FRIIS MOGENS LAUE,PAULSON OLAF BJARNE,HERTZ MARIANNE MARGRETHE

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.1979.tb02915.x/fullpdf

Reference29 articles.

1. Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration in man;Aellig;Int. J. Clin. Pharmacol,1977

2. Galactorrhoea: Successful treatment with reduction of plasma prolactin levels by brom-ergocryptine;Besser;Brit. Med. J,1972

3. Hyperprolactinemic anovulatory syndrome;Bohnet;J. Clin. Endocrinol. Metab,1976

4. The permeability of the blood-brain barrier during electrically induced seizures in man;Bolwig;Europ. J. Clin. Invest,1977

5. Bromocriptine in Parkinsonism;Calne;Brit. Med. J,1974 a

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects;International Journal of Molecular Sciences;2023-08-26

2. Dopamine receptor D1- and D2-agonists do not spark brown adipose tissue thermogenesis in mice;Scientific Reports;2020-11-19

3. Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease;Stem Cell Reports;2020-06

4. Identification of approved drugs that inhibit the binding of amyloid β oligomers to ephrin type‐B receptor 2;FEBS Open Bio;2016-04

5. Neuroendocrine studies in dementia patients: responses of plasma GH and PRL following bromocriptine administration;Acta Neurologica Scandinavica;2009-01-29